Here are four observations.
1. Key market players include DePuy Synthes, Globus Medical, Medtronic, NuVasive, Stryker and Zimmer Biomet.
2. An increasing number of spinal disorder cases are driving the market.
3. The demand for spine biologics represents a growing market trend.
4. Complications related to spine devices and surgeries will present a barrier to market growth.
More articles on devices:
NuVasive, OrthoPediatrics & more: 4 device company launches, releases
Global thoracolumbar spine devices market to grow at 3.8% CAGR through 2022: 4 observations
How will proposed Trump, China tariffs affect medtech and healthcare? 5 key thoughts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
